Kao HF, Liao BC, Huang YL, Huang HC, et al. Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis. Clin Cancer Res 2022 Jan 19. pii: 1078-0432.CCR-21-3025.
PMID: 35046059